{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:35:30Z","timestamp":1762878930525,"version":"3.45.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03891-4","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:57:12Z","timestamp":1762873032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell hdWGCNA identifies ICI\u2013related\u2013colitis key CD8\u2009+\u2009T cells linked to immunotherapy response and prognosis in colon cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Shuiqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaocong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingquan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"3891_CR1","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.2147\/CMAR.S268943","volume":"12","author":"S Han","year":"2020","unstructured":"Han S, Zhuang J, Wu Y, Wu W, Yang X. Progress in research on colorectal Cancer-Related microorganisms and metabolites. Cancer Manag Res. 2020;12:8703\u201320.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"3891_CR2","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye B, Fan J, Xue L, Zhuang Y, Luo P, Jiang A, Xie J, Li Q, Liang X, Tan J, et al. iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta. 2025;4(2):e70011.","journal-title":"Imeta"},{"issue":"1","key":"3891_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11523-019-00690-0","volume":"15","author":"R Cohen","year":"2020","unstructured":"Cohen R, Rousseau B, Vidal J, Colle R, Diaz LA Jr., Andre T. Immune checkpoint Inhibition in colorectal cancer: microsatellite instability and beyond. Target Oncol. 2020;15(1):11\u201324.","journal-title":"Target Oncol"},{"issue":"1","key":"3891_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00384-021-04028-z","volume":"37","author":"T Zeng","year":"2022","unstructured":"Zeng T, Fang X, Lu J, Zhong Y, Lin X, Lin Z, Wang N, Jiang J, Lin S. Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(1):251\u20138.","journal-title":"Int J Colorectal Dis"},{"key":"3891_CR5","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3389\/fimmu.2019.01816","volume":"10","author":"F Ghiringhelli","year":"2019","unstructured":"Ghiringhelli F, Fumet JD. Is there a place for immunotherapy for metastatic microsatellite stable colorectal cancer? Front Immunol. 2019;10:1816.","journal-title":"Front Immunol"},{"key":"3891_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","volume":"62","author":"N Krishnamurthy","year":"2018","unstructured":"Krishnamurthy N, Kurzrock R. Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50\u201360.","journal-title":"Cancer Treat Rev"},{"issue":"25","key":"3891_CR7","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 Inhibition. N Engl J Med. 2017;377(25):2500\u20131.","journal-title":"N Engl J Med"},{"issue":"6","key":"3891_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","volume":"16","author":"MG Rooks","year":"2016","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341\u201352.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3891_CR9","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1002\/imt2.130","volume":"2","author":"L Liu","year":"2023","unstructured":"Liu L, Xie Y, Yang H, Lin A, Dong M, Wang H, Zhang C, Liu Z, Cheng Q, Zhang J, et al. HPVTIMER: A Shiny web application for tumor immune Estimation in human papillomavirus-associated cancers. Imeta. 2023;2(3):e130.","journal-title":"Imeta"},{"issue":"10","key":"3891_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14(10):667\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"3891_CR11","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cell.2016.11.046","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, Horst RT, Jansen T, Jacobs L, Bonder MJ, et al. Linking the human gut Microbiome to inflammatory cytokine production capacity. Cell. 2016;167(7):1897.","journal-title":"Cell"},{"issue":"7351","key":"3891_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307\u201317.","journal-title":"Nature"},{"issue":"2","key":"3891_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bpg.2003.10.002","volume":"18","author":"L Beaugerie","year":"2004","unstructured":"Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol. 2004;18(2):337\u201352.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"3891_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, et al. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell Commun Signal. 2022;20(1):44.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"3891_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","volume":"71","author":"N Okiyama","year":"2022","unstructured":"Okiyama N, Tanaka R. Immune-related adverse events in various organs caused by immune checkpoint inhibitors. Allergol Int. 2022;71(2):169\u201378.","journal-title":"Allergol Int"},{"issue":"1","key":"3891_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","volume":"7","author":"S Das","year":"2019","unstructured":"Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019;7(1):306.","journal-title":"J Immunother Cancer"},{"key":"3891_CR17","doi-asserted-by":"publisher","first-page":"768957","DOI":"10.3389\/fimmu.2021.768957","volume":"12","author":"H Westdorp","year":"2021","unstructured":"Westdorp H, Sweep MWD, Gorris MAJ, Hoentjen F, Boers-Sonderen MJ, van der Post RS, van den Heuvel MM, Piet B, Boleij A, Bloemendal HJ, et al. Mechanisms of immune checkpoint Inhibitor-Mediated colitis. Front Immunol. 2021;12:768957.","journal-title":"Front Immunol"},{"issue":"2","key":"3891_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41416-020-0882-y","volume":"123","author":"VTF Cheung","year":"2020","unstructured":"Cheung VTF, Gupta T, Olsson-Brown A, Subramanian S, Sasson SC, Heseltine J, Fryer E, Collantes E, Sacco JJ, Pirmohamed M, et al. Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way? Br J Cancer. 2020;123(2):207\u201315.","journal-title":"Br J Cancer"},{"issue":"3","key":"3891_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","volume":"182","author":"AM Luoma","year":"2020","unstructured":"Luoma AM, Suo S, Williams HL, Sharova T, Sullivan K, Manos M, Bowling P, Hodi FS, Rahma O, Sullivan RJ, et al. Molecular pathways of colon inflammation induced by cancer immunotherapy. Cell. 2020;182(3):655\u2013e671622.","journal-title":"Cell"},{"key":"3891_CR20","first-page":"101600","volume":"37","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Ye Y, Zhang Q, Wu Y, Wang G, Gui Z, Zhang M. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma. Biochem Biophys Rep. 2024;37:101600.","journal-title":"Biochem Biophys Rep"},{"issue":"5","key":"3891_CR21","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.21037\/tcr-24-1976","volume":"14","author":"X Jin","year":"2025","unstructured":"Jin X, Yang J, Li D, Zhang W, Zhang Q, Li M, Ye Y, Chen Z. Comprehensive assessment of disulfidptosis-related long non-coding RNA index as biomarkers for predicting clinical outcomes and immune microenvironment in pancreatic cancer. Transl Cancer Res. 2025;14(5):2758\u201378.","journal-title":"Transl Cancer Res"},{"issue":"8","key":"3891_CR22","doi-asserted-by":"publisher","first-page":"e29869","DOI":"10.1016\/j.heliyon.2024.e29869","volume":"10","author":"L Bao","year":"2024","unstructured":"Bao L, Ye Y, Zhang X, Xu X, Wang W, Jiang B. Identification and verification of a PANoptosis-related long noncoding ribonucleic acid signature for predicting the clinical outcomes and immune landscape in lung adenocarcinoma. Heliyon. 2024;10(8):e29869.","journal-title":"Heliyon"},{"issue":"1","key":"3891_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13062-024-00588-6","volume":"19","author":"L Bao","year":"2024","unstructured":"Bao L, Wu Y, Ren Z, Huang Y, Jiang Y, Li K, Xu X, Ye Y, Gui Z. Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway. Biol Direct. 2024;19(1):139.","journal-title":"Biol Direct"},{"issue":"16","key":"3891_CR24","doi-asserted-by":"publisher","first-page":"15069","DOI":"10.1007\/s00432-023-05285-x","volume":"149","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Ye Y, Huang Y, Wu Y, Wang G, Gui Z, Zhang M, Zhang M. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response. J Cancer Res Clin Oncol. 2023;149(16):15069\u201383.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"3891_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"3891_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19(1):15.","journal-title":"Genome Biol"},{"issue":"1","key":"3891_CR27","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, Yu F, Li L, Huang R, Zhang P, Kadier K, Wang Y, Gu Q, et al. Optimized dynamic network biomarker Deciphers a High-Resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1(1):10\u201331.","journal-title":"Med Res"},{"issue":"4","key":"3891_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in Single-Cell transcriptomic data. Cell Syst. 2019;8(4):281\u201391. e289.","journal-title":"Cell Syst"},{"issue":"12","key":"3891_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"issue":"D1","key":"3891_CR30","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, Chen J, Jiang W, Yang K, Ou Q, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3891_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"6","key":"3891_CR32","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. HdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods. 2023;3(6):100498.","journal-title":"Cell Rep Methods"},{"issue":"4","key":"3891_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"12","key":"3891_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"3","key":"3891_CR35","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"1","key":"3891_CR36","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"11","key":"3891_CR37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"12","key":"3891_CR38","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"10","key":"3891_CR39","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"3891_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"3891_CR41","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"key":"3891_CR42","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, et al. IOBR: Multi-Omics Immuno-Oncology biological research to Decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"1","key":"3891_CR43","first-page":"136","volume":"1","author":"Y Fang","year":"2025","unstructured":"Fang Y, Kong Y, Rong G, Luo Q, Liao W, Zeng D. Systematic investigation of tumor microenvironment and antitumor immunity with IOBR. Med Res. 2025;1(1):136\u201340.","journal-title":"Med Res"},{"key":"3891_CR44","doi-asserted-by":"publisher","first-page":"175628482110020","DOI":"10.1177\/17562848211002018","volume":"14","author":"SM Manz","year":"2021","unstructured":"Manz SM, Losa M, Fritsch R, Scharl M. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Th Adv Gastroenterol. 2021;14:17562848211002018.","journal-title":"Th Adv Gastroenterol"},{"key":"3891_CR45","doi-asserted-by":"publisher","first-page":"800879","DOI":"10.3389\/fimmu.2021.800879","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, Wang J, Lin N, Zhou Y, He W, Liu J, Ma X. Immune checkpoint Inhibitor-Associated colitis: from mechanism to management. Front Immunol. 2021;12:800879.","journal-title":"Front Immunol"},{"issue":"6","key":"3891_CR46","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li J, Wu C, Hu H, Qin G, Wu X, Bai F, Zhang J, Cai Y, Huang Y, Wang C, et al. Remodeling of the immune and stromal cell compartment by PD-1 Blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 2023;41(6):1152\u201369. e1157.","journal-title":"Cancer Cell"},{"issue":"10","key":"3891_CR47","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/ecco-jcc\/jjx081","volume":"11","author":"C Coutzac","year":"2017","unstructured":"Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, Boselli L, Kamsukom N, Mateus C, Charrier M, et al. Colon Immune-Related adverse events: Anti-CTLA-4 and Anti-PD-1 Blockade induce distinct immunopathological entities. J Crohns Colitis. 2017;11(10):1238\u201346.","journal-title":"J Crohns Colitis"},{"issue":"23","key":"3891_CR48","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andre","year":"2020","unstructured":"Andre T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, et al. Pembrolizumab in Microsatellite-Instability-High advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"3891_CR49","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182\u201391.","journal-title":"Lancet Oncol"},{"issue":"26","key":"3891_CR50","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et al. PD-1 Blockade in tumors with Mismatch-Repair deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med"},{"issue":"9","key":"3891_CR51","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/eji.201141477","volume":"41","author":"TJ Slebioda","year":"2011","unstructured":"Slebioda TJ, Rowley TF, Ferdinand JR, Willoughby JE, Buchan SL, Taraban VY, Al-Shamkhani A. Triggering of TNFRSF25 promotes CD8(+) T-cell responses and anti-tumor immunity. Eur J Immunol. 2011;41(9):2606\u201311.","journal-title":"Eur J Immunol"},{"key":"3891_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fimmu.2019.00583","volume":"10","author":"V Valatas","year":"2019","unstructured":"Valatas V, Kolios G, Bamias G. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory system of cytokines with diverse functions in gut mucosal immunity. Front Immunol. 2019;10:583.","journal-title":"Front Immunol"},{"issue":"11","key":"3891_CR53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","volume":"20","author":"R Rosenzweig","year":"2019","unstructured":"Rosenzweig R, Nillegoda NB, Mayer MP, Bukau B. The Hsp70 chaperone network. Nat Rev Mol Cell Biol. 2019;20(11):665\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3891_CR54","doi-asserted-by":"crossref","unstructured":"Albakova Z, Armeev GA, Kanevskiy LM, Kovalenko EI, Sapozhnikov AM. HSP70 Multi-Functionality in cancer. Cells 2020;9(3):587.","DOI":"10.3390\/cells9030587"},{"issue":"12","key":"3891_CR55","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/iub.2157","volume":"71","author":"R Moradi-Marjaneh","year":"2019","unstructured":"Moradi-Marjaneh R, Paseban M, Moradi Marjaneh M. Hsp70 inhibitors: implications for the treatment of colorectal cancer. IUBMB Life. 2019;71(12):1834\u201345.","journal-title":"IUBMB Life"},{"issue":"1","key":"3891_CR56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13046-019-1117-z","volume":"38","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhou R, Zhang W, Yao X, Li W, Xu L, Sun X, Zhao L. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation. J Exp Clin Cancer Res. 2019;38(1):120.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03891-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03891-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:04:25Z","timestamp":1762877065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03891-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03891-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2084"}}